SCHEMBL4405057

SCHEMBL4405057

C=COC1CCC(C(C)(C)C)CC1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.34
HTT P42858 3/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP19A1 P11511 1/20 0.32
LIPA P38571 1/20 0.32
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13100636 0.86
SCHEMBL804962 0.80
SCHEMBL65094 0.80
SCHEMBL19625940 0.79
SCHEMBL3234183 0.79
SCHEMBL3234175 0.79
SCHEMBL503730 0.77 LIPA (0.39) MAPTHTTMEN1KMT2AAPOBEC3A
SCHEMBL3158779 0.73
SCHEMBL19428087 0.73
SCHEMBL2863383 0.73 MAPT (0.37) MAPTHTTMEN1KMT2AAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858670-B2 Photosensitive inkjet ink TOSHIBA TEC KABUSHIKI KAISHA (JP) 2010-12-28 US disclosed
US-7858670-B2 Photosensitive inkjet ink TOSHIBA TEC KABUSHIKI KAISHA (JP) 2010-12-28 US disclosed
US-20100026771-A1 INKJET RECORDING METHOD, INKJET RECORDING SYSTEM, AND PRINTED MATERIAL FUJIFILM CORPORATION (JP) 2010-02-04 US disclosed
US-20100026771-A1 INKJET RECORDING METHOD, INKJET RECORDING SYSTEM, AND PRINTED MATERIAL FUJIFILM CORPORATION (JP) 2010-02-04 US disclosed
EP-2149457-A2 Inkjet recording method, inkjet recording system, and printed material Fujifilm Corporation (JP) 2010-02-03 EP disclosed
EP-1146033-B1 Fragrance precursors GIVAUDAN SA (CH) 2009-12-23 EP disclosed
US-7473720-B2 Photosensitive inkjet ink TOSHIBA TEC KABUSHIKI KAISHA (JP) 2009-01-06 US disclosed
US-7473720-B2 Photosensitive inkjet ink TOSHIBA TEC KABUSHIKI KAISHA (JP) 2009-01-06 US disclosed
US-7375145-B2 capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound TOSHIBA TEC KABUSHIKI KAISHA (JP) 2008-05-20 US disclosed
US-7375145-B2 capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound TOSHIBA TEC KABUSHIKI KAISHA (JP) 2008-05-20 US disclosed
EP-1528088-B1 Inkjet ink TOSHIBA TEC KK (JP) 2008-02-27 EP disclosed
US-20070270520-A1 Capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound RISO TECHNOLOGIES CORPORATION (JP) 2007-11-22 US disclosed
US-20070270520-A1 Capable of overcoming the problems such as poor cation polymerizing reaction and solvent resistance which are particularly accompanied with the conventional photosensitive inkjet ink containing, as a main component, a vinyl ether compound RISO TECHNOLOGIES CORPORATION (JP) 2007-11-22 US disclosed
US-20070185224-A1 PHOTOSENSITIVE INKJET INK KABUSHIKI KAISHA TOSHIBA (JP) 2007-08-09 US disclosed
US-20070185224-A1 PHOTOSENSITIVE INKJET INK KABUSHIKI KAISHA TOSHIBA (JP) 2007-08-09 US disclosed
US-20070101898-A1 Inkjet ink AKIYAMA RYOZO 2007-05-10 US disclosed
US-20070101898-A1 Inkjet ink AKIYAMA RYOZO 2007-05-10 US disclosed
US-6492563-B2 PROVIDES NON-VOLATILE PRECURSORS FOR VOLATILE FRAGRANT ESTERS FOR USE IN DETERGENT, A FABRIC SOFTENER, A WINDOW CLEANER, A HARD SURFACE CLEANER, AN ALL PURPOSE CLEANER, A FURNITURE POLISH, A SHAMPOO, A CONDITIONER, AN HAIRSPRAY, A COSMETIC GIVAUDAN SA (CH) 2002-12-10 US disclosed
US-20020077508-A1 Fragrance precursors GIVAUDAN SA (CH) 2002-06-20 US disclosed
EP-1146033-A2 Fragrance precursors Givaudan SA (CH) 2001-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077508-A1 Fragrance precursors ADH5, FAAH, CBR3 MAPT 4053/4885HTT 4313/4885MEN1 2890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.